Sigma-Aldrich Corporation

Sigma-Aldrich Corporation specializes in in vitro diagnostic (IVD) reagents and solutions primarily used for preparing and staining microscope slides. Their products include differentiation solutions like modified Giemsa stains, hematoxylin solutions (such as Gill No 1 and Mayer’s), May-Grünwald stains, and Papanicolaou stains, which are essential for hematology and cytopathology. These reagents help visualize cellular and tissue structures under a microscope, aiding in diagnostic evaluations.

Sigma-Aldrich Corporation is based in the United States. As a US-based manufacturer, its IVD devices are subject to FDA regulations in the US market and EU regulations (such as IVDR) if marketed in the European Union. The company’s products are registered in the EU’s EUDAMED database and the US FDA’s Unique Device Identifier (UDI) system, demonstrating compliance with relevant regulatory requirements in those regions.

Sigma-Aldrich Corporation’s devices are listed in the EU’s EUDAMED database and the US FDA’s Unique Device Identifier (UDI) system. These registries are critical because they provide transparency on device authorization status, manufacturer details, and regulatory compliance. For example, EUDAMED ensures traceability under the EU In Vitro Diagnostic Regulation (IVDR), while the FDA’s UDI system supports tracking and recall management in the US. Listing in these databases helps healthcare professionals and regulators verify the legitimacy and classification of the devices.

Sigma-Aldrich Corporation’s IVD devices are classified as EU IVD Class A and US FDA Class I. These classifications indicate that the devices pose a low risk to patients and users. Class A/Class I devices typically involve minimal or no risk (e.g., routine laboratory reagents), requiring less stringent premarket scrutiny compared to higher-risk devices. The classification ensures that only appropriate regulatory oversight is applied, balancing safety with operational efficiency for low-risk diagnostic tools.